DNYUZ
No Result
View All Result
DNYUZ
No Result
View All Result
DNYUZ
Home News

People Taking Gray Market Peptides Say They’re Causing Bizarre Medical Issues

October 14, 2026
in News
People Taking Gray Market Peptides Say They’re Causing Bizarre Medical Issues

With gray market medical snake oil flooding the market and the head of the Food and Drug Administration smoking DMT behind the wheel, peptides are quickly becoming the go-to hack for just about any malady you can imagine. Yet for as popular as they are, they’re not necessarily safe to use — a fact many new users are starting to discover the hard way.

New reporting by KFF Health News revealed the story of Dylan Meetze, a weightlifter who bought an experimental peptide intended for laboratory research from a company called Researchem. Meetze’s peptide of choice was BPC-157, a synthetic substance derived from 15 amino acids and prized by YouTubers for its supposed ability to reduce inflammation and repair damaged tissue.

For Meetze, BPC-157 was a way to enhance his weightlifting performance. Yet after spraying the stuff up his nose for just three days, KFF notes the peptide user fell seriously ill.

“It was like I was underwater, like it took the most to do anything,” Meetze told the outlet.

Though he stopped huffing BPC-157 almost as soon as the side effects appeared, the weightlifter said he endured fatigue and anxiety, as well as eye and muscle spasms for months afterward.

“There are millions of success stories with these peptides,” he told KFF, “but no one wants to believe that this wrecks some of our lives.”

Another peptide user who combined BPC-157 with a naturally-occurring protein called TB-4 told KFF that his side effects also came within days of beginning the experimental treatment.

“My left eye started throbbing really badly, and the left side of my face became numb,” the man, identified only as Dominik E, told the publication. He went on to battle migraines for two months, calling the ordeal a “total nightmare.”

Certain peptides have become established treatments after passing clinical trials, like GLP-1 drugs for diabetes and weight loss.

But for the many other peptides that haven’t undergone clinical review, supporters in the medical research community are few and far between, despite what the chorus of pro-peptide comedians and health influencers would have you believe. Robust studies on their impact on human health remain exceedingly rare — making any use of unregulated peptides on the human body a serious roll of the dice.

“A lot of this pseudoscience stuff sounds deeply impressive — inflammation this and telomere that — but at the end of the day, none of it really matters,” former associate commissioner for public health strategy and analysis at the FDA Peter Lurie told KFF. “You’ve got to show clinical benefit in humans: does it work?”

More on peptides: Pete Davidson Has Been Crushing Black Market Peptides to Get Disgustingly Swole

The post People Taking Gray Market Peptides Say They’re Causing Bizarre Medical Issues appeared first on Futurism.

As Ukraine Raises Alarm Over U.S. Backing, Europeans Pledge Support
News

As Ukraine Raises Alarm Over U.S. Backing, Europeans Pledge Support

by New York Times
October 14, 2026

European leaders vowed to redouble their support for Ukraine on Wednesday, amid fears that President Trump could stop or cut ...

Read more
News

Before N.W.A., Dr. Dre Was Making Electro-Rap in a Sequined Jumpsuit

October 14, 2026
News

Five Who Lived Along Walking Trail Are Dead and the Police Hunt a Killer

October 14, 2026
News

California’s Prop 45 aims to speed construction projects. Opponents say data centers will benefit

October 14, 2026
News

Trump’s tilting at windmills could skewer landmark permitting reform

October 14, 2026
Max Miller’s lawyer accused of trying to ‘extort’ girlfriend’s ex in dead dog letter

Max Miller’s lawyer accused of trying to ‘extort’ girlfriend’s ex in dead dog letter

October 14, 2026
Frank Mancuso Has Died. He Was Behind Hit Movies of the 1980s and ’90s.

Frank Mancuso Has Died. He Was Behind Hit Movies of the 1980s and ’90s.

October 14, 2026
25 years ago, Netflix laid off a third of its employees and learned a lesson about ‘talent density.’ New cuts will test whether it still works

25 years ago, Netflix laid off a third of its employees and learned a lesson about ‘talent density.’ New cuts will test whether it still works

October 14, 2026

DNYUZ © 2026

No Result
View All Result

DNYUZ © 2026